Practolol in angina

Phear, D N
March 1971
British Medical Journal;3/6/1971, Vol. 1 Issue 5748, p557
Academic Journal
No abstract available.


Related Articles

  • Double-blind Comparison of Tolamolol, Propranolol, Practolol, and Placebo in the Treatment of Angina Pectoris. Jackson, Graham; Atkinson, Lynne; Oram, Samuel // British Medical Journal;3/29/75, Vol. 1 Issue 5960, p708 

    Compares the performance among tolamolol, propranolol, practolol and placebo in the treatment of angina pectoris. Selection of an adequate dose level of the drug; Effect of propranolol on the resting heart rate; Influence of tolamolol on the reduction of blood pressure.

  • Side Effects of Practolol.  // British Medical Journal;6/14/1975, Vol. 2 Issue 5971, p577 

    Examines the side effects of practolol in Great Britain. Medical implications of practolol; Application of topical steroids in the severe cases; Usage of intravenous practolol in the management of acute dysrhythmias.

  • Hazards of non-practolol beta-blockers.  // British Medical Journal;2/26/1977, Vol. 1 Issue 6060, p529 

    Focuses on the health hazards of non-practolol beta-blockers. Adverse reactions of beta-adrenoceptor antagonism; Association of oculomucocutaneous syndrome with practolol; Discussion on the practolol syndrome.

  • Pneumatosis coli: complication of practolol. Thein, S.L.; Asquith, P. // British Medical Journal;1/29/1977, Vol. 1 Issue 6056, p268 

    Reports the induction of pneumatosis coli by practolol. Mechanisms for the development of the coli; Development of severe gastrointestinal symptoms after long-time administration of practolol; Conclusion on the mechanisms in the induction of the coli by practolol.

  • Tear fluid lysozyme concentration: guide to practolol toxicity. Mackie, I.A.; Seal, D.V. // British Medical Journal;12/27/1975, Vol. 4 Issue 5999, p732 

    Investigates the use of tear lysozyme concentration in screening for practolol toxicity. Usefulness of the screening test; Appearance of ocular toxicity; Association of conjunctivitis or corneal damage with practolol treatment.

  • Search for late-onset side effects of practolol. Barclay, J.; Ramsay, L.E.; Jay, J.L.; McQueen, A.; Lorimer, A.R. // British Medical Journal;8/19/1978, Vol. 2 Issue 6136, p538 

    Examines the side effects of practolol on patients with pulmonary complications in Glasgow, Scotland. Documentation of oculomucocutaneous syndrome; Exposure of patients to practolol toxicity; Sensitivity of intercellular antibody on toxicity index.

  • Untoward Effects Associated with Practolol Administration: Oculomucocutaneous Syndrome.  // British Medical Journal;3/15/1975, Vol. 1 Issue 5958, p595 

    Examines the side effects of practolol administration in oculomucocutaneous syndrome. Conjunctiva scarring with tear flow reduction; Initial signs for the syndrome; Treatment of the adverse reactions through rehydration.

  • Untoward Effects Associated with Practolol: Demonstration of Antibody Binding to Epithelial Tissue. Wright, Peter // British Medical Journal;3/15/1975, Vol. 1 Issue 5958, p598 

    Examines the effect of practolol administration in on the binding of antibodies to epithelial tissue. Description of the conjunctival signs; Immunological investigation of antibody sera; Use of immunofluorescence in diagnosing the disease.

  • CORRESPONDENCE. Wright, Peter; Fallon, R.J.; Lawson, James H.; Longson, Maurice; Juel-Jensen, B.E.; Liversedge, L.A.; Peart, W.S.; Miall, W.E.; Crowther, Andrew; Gray, Brian; Rogers, Robert; Lacey, R.W.; Vedin, J. Anders; Wilhelmson, Claes E.; Spodick, David H.; Roy, S.K.; Mathews, J.A.; Child, D.L. // British Medical Journal;12/6/1975, Vol. 4 Issue 5996, p577 

    Presents several letters concerning medicine. Ocular reactions to beta-blocking drugs; Treatment of meningitis and encephalitis; Long-term postinfarction treatment with practolol.

  • Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. Amos, H.E.; Lake, B.G.; Artis, J. // British Medical Journal;2/18/78, Vol. 1 Issue 6110, p402 

    The clinical distribution of an antibody to a metabolite of practolol was investigated, particularly in relation to the oculomucocutaneous syndrome, Serum samples were obtained from patients with and without a history of adverse reaction to practolol and two groups of control patients who had...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics